Literature DB >> 3725872

[The potential antineoplastic acting constituents of Physalis alkekengi L. var franchetii Mast].

K Dornberger.   

Abstract

In a continuing search for potent antineoplastic compounds in indigenous plants, a water extract of Physalis alkekengi L. var. franchetii Mast. fruits was shown to have reproducible antineoplastic activity against Ehrlich ascites carcinoma in mice. Systematic fractionation of the extract led to the isolation of citric acid as the major active principle.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3725872

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  2 in total

1.  Bioactivity-guided fractionation of the triglyceride-lowering component and in vivo and in vitro evaluation of hypolipidemic effects of Calyx seu Fructus Physalis.

Authors:  Yihui Yang; Xianmei Piao; Mingyu Zhang; Xiaodan Wang; Bing Xu; Jiuxin Zhu; Zhiwei Fang; Yunlong Hou; Yanjie Lu; Baofeng Yang
Journal:  Lipids Health Dis       Date:  2012-03-14       Impact factor: 3.876

2.  Inhibitory Effects of Physalis alkekengi L., Alcea rosea L., Bunium persicum B. Fedtsch. and Marrubium vulgare L. on Mushroom Tyrosinase.

Authors:  Foroogh Namjoyan; Alireza Jahangiri; Mohammad Ebrahim Azemi; Elaheh Arkian; Hamideh Mousavi
Journal:  Jundishapur J Nat Pharm Prod       Date:  2015-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.